Status:
COMPLETED
Preoperative Imaging in Patients With Small Bowel Neuroendocrine Tumors
Lead Sponsor:
Laurent BRUNAUD
Conditions:
Neuroendocrine Tumors
Small Intestinal NET
Eligibility:
All Genders
16-95 years
Brief Summary
Digestive NETs are the second most common malignant digestive tumor after adenocarcinoma. The most common gastrointestinal NETs arise from the small intestine. These tumors have a high lymph node and ...
Detailed Description
Digestive neuroendocrine tumors (NET) are developed from neuroendocrine cells, of epithelial origin, scattered throughout the digestive tract. These tumors form a heterogeneous group defined according...
Eligibility Criteria
Inclusion
- Patients with neuroendocrine tumors who underwent a scheduled surgical procedure for small bowel resection
Exclusion
- patients without preoperative CT scan
- patients with abdominal resection performed in emergency
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 11 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05246319
Start Date
January 1 2012
End Date
February 11 2025
Last Update
February 12 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU Nancy
Nancy, France, 54000
2
CHRU Nancy - Département Chirurgie Viscérale, Métabolique et Cancérologique CVMC (7ème étage)
Nancy, France, 54511